Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
SY1-H5225 | Human | Human Syndecan-1 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
SY1-H5253 | Human | Human Syndecan-1 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
SD1-HF228 | Human | FITC-Labeled Human Syndecan-1 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
SY1-H82F3 | Human | Biotinylated Human Syndecan-1 Protein, Fc,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
SY1-H82E2 | Human | Biotinylated Human Syndecan-1 Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
2e5 of anti-Syndecan-1 CAR-293 cells were stained with 100 μL of 3 μg/mL of Human Syndecan-1, His Tag (Cat. No. SY1-H5225) and negative control protein respectively, washed and then followed by PE anti-His Tag antibody and analyzed with FACS (Routinely tested).
2e5 of anti-Syndecan-1 CAR-293 cells were stained with 100 μL of 0.3 μg/mL of Human Syndecan-1, Fc Tag (Cat. No. SY1-H5253) and negative control protein respectively, washed and then followed by PE anti-human IgG Fc antibody and analyzed with FACS (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center) | Phase 1 Clinical | Unc Lineberger Comprehensive Cancer Center | Immune System Diseases; Multiple Myeloma | Details |
This web search service is supported by Google Inc.